Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SPIRONOLACTONE Cause Concomitant disease aggravated? 8 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Concomitant disease aggravated have been filed in association with SPIRONOLACTONE (spironolactone). This represents 0.0% of all adverse event reports for SPIRONOLACTONE.

8
Reports of Concomitant disease aggravated with SPIRONOLACTONE
0.0%
of all SPIRONOLACTONE reports
5
Deaths
4
Hospitalizations

How Dangerous Is Concomitant disease aggravated From SPIRONOLACTONE?

Of the 8 reports, 5 (62.5%) resulted in death, 4 (50.0%) required hospitalization, and 1 (12.5%) were considered life-threatening.

Is Concomitant disease aggravated Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SPIRONOLACTONE. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does SPIRONOLACTONE Cause?

Acute kidney injury (3,273) Hyperkalaemia (2,518) Hypotension (1,583) Dyspnoea (1,468) Drug ineffective (1,379) Hyponatraemia (1,166) Dizziness (991) Fatigue (990) Fall (947) Off label use (899)

What Other Drugs Cause Concomitant disease aggravated?

SACUBITRIL\VALSARTAN (533) SECUKINUMAB (461) FINGOLIMOD (425) MACITENTAN (286) OMALIZUMAB (186) SELEXIPAG (166) METHOTREXATE (150) RUXOLITINIB (142) OCTREOTIDE (125) BOSENTAN (123)

Which SPIRONOLACTONE Alternatives Have Lower Concomitant disease aggravated Risk?

SPIRONOLACTONE vs SPRYCEL SPIRONOLACTONE vs STALEVO SPIRONOLACTONE vs STANNOUS FLUORIDE SPIRONOLACTONE vs STANOZOLOL SPIRONOLACTONE vs STAVUDINE

Related Pages

SPIRONOLACTONE Full Profile All Concomitant disease aggravated Reports All Drugs Causing Concomitant disease aggravated SPIRONOLACTONE Demographics